304 North Cardinal St. Dorchester Center, MA 02124
Tag Niraparib
Niraparib, brand name zejula, an anti cancer medicine used in treating epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is an oral medicine.
A PARP inhibitor is a cancer drug that blocks the activity of poly(ADP-ribose) polymerase (PARP), a protein crucial for DNA repair, leading to cell death in various cancers, including ovarian, breast, prostate, pancreatic, and fallopian tube cancers.